Aibo Medical Announces Up to RMB 100 Million Capital Injection into Unicon Optics to Advance 'Medical Plus Consumer' Strategy

Eyebright Medical (688050.SH) announced that in order to promote the strategic layout of the company's overall industrial development, help the company seek new market opportunities, and form new revenue growth points, the company plans to use no more than 100 million yuan of its own funds to make a paid-in capital increase in Unicon. Unicon is deeply engaged in the field of contact lens manufacturing. The purpose of this capital increase is to implement the company’s long-term sustainable development strategy of "medical plus consumer."